Lansoprazole Export Market Intelligence: India's 316 Suppliers Shipping to 105 Countries — TransData Nexus 2026

Q: Who are the top lansoprazole exporters from India?

The top lansoprazole exporters from India are: 1. SANDOZ PRIVATE LIMITED — $159.0M (54.8% market share); 2. MYLAN LABORATORIES LIMITED — $26.5M (9.1% market share); 3. PAR FORMULATIONS PRIVATE LIMITED — $19.8M (6.8% market share); 4. LINCOLN PHARMACEUTICALS LTD — $14.9M (5.1% market share); 5. CIPLA LIMITED — $11.3M (3.9% market share). Together they account for 79.8% of India's total lansoprazole export value.

Q: What is the total export value of lansoprazole from India?

The total export value of lansoprazole from India is $290.2M USD, recorded across 4,867 shipment transactions from 316 active exporters to 105 destination countries. The average shipment value is $59.6K.

Q: Which countries import lansoprazole from India?

India exports lansoprazole to 105 countries worldwide. The top importing countries are: CANADA (54.9% share, $159.4M), UNITED STATES (20.7% share, $60.2M), TANZANIA (5.0% share, $14.6M), FRANCE (3.1% share, $9.1M), GUATEMALA (2.9% share, $8.3M). These five markets account for 86.7% of total export value.

Q: What is the HS code for lansoprazole exports from India?

The primary HS code for lansoprazole exports from India is 30049034. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of lansoprazole exports from India?

The average unit price for lansoprazole exports from India is $15.78 USD per unit, with prices ranging from $0.01 to $2380.38 depending on formulation, packaging, and order volume. The total market is valued at $290.2M across 4,867 shipments.

Q: Which ports handle lansoprazole exports from India?

The primary ports for lansoprazole exports from India are SAHAR AIR (15.0% of shipments), DELHI AIR CARGO ACC (INDEL4) (11.9% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.5% of shipments), DELHI AIR (7.5% of shipments), NHAVA SHEVA SEA (INNSA1) (5.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of lansoprazole?

India is one of the world's leading exporters of lansoprazole due to its large base of 316 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports lansoprazole to 105 countries, demonstrating 54% global market coverage.

Q: What certifications do Indian lansoprazole exporters need?

Indian lansoprazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import lansoprazole from India?

There are 687 registered buyers importing lansoprazole from India, spread across 105 countries. The repeat buyer rate is 58.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top lansoprazole supplier from India?

SANDOZ PRIVATE LIMITED is the leading lansoprazole exporter from India with a market share of 54.8% and total export value of $159.0M across 69 shipments. The top 5 suppliers together control 79.8% of total export value.

Suresh Sormare

Lansoprazole

India Pharmaceutical Trade Intelligence

$290.2M316 Suppliers105 CountriesHS 30049034

ExportsIndia → CANADA54.9%India → UNITED STATES20.7%

ImportsISRAEL → India$8.3M UNITED STATES → India$178.0K

#1 Supplier: SANDOZ PRIVATE #1 Buyer: SANDOZ CANADA

Lansoprazole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Lansoprazole to the World

Between 2022 and 2026, India exported $290.2M worth of lansoprazole across 4,867 verified shipments to 105 countries — covering 54% of world markets in the Gastrointestinal segment. The largest destination is CANADA (54.9%). SANDOZ PRIVATE LIMITED leads with a 54.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Lansoprazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Lansoprazole export data snapshot — $290.2M · 316 exporters · 105 countriesTransData Nexus · Indian Customs Data

Top Lansoprazole Exporters from India

316 active exporters · Ranked by export value

View all 316 →

Top Lansoprazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SANDOZ PRIVATE LIMITED	$159.0M	69	2	54.8%
2	MYLAN LABORATORIES LIMITED

Top Countries Importing Lansoprazole from India

105 destination markets · Ranked by import value

All 105 countries →

Top Countries Importing Lansoprazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	CANADA	$159.4M	54.9%
2	UNITED STATES	$60.2M	20.7%
3	TANZANIA	$14.6M	5.0%
4	FRANCE	$9.1M	3.1%
5	GUATEMALA	$8.3M	2.9%
6	SOUTH AFRICA	$5.8M	2.0%
7	NETHERLANDS	$4.7M	1.6%
8	KENYA	$4.2M	1.5%
9	OMAN	$2.3M	0.8%
10	AFGHANISTAN	$2.0M	0.7%

CANADA is India's largest lansoprazole export destination, absorbing 54.9% of total exports worth $159.4M. The top 5 importing countries — CANADA, UNITED STATES, TANZANIA, FRANCE, GUATEMALA — together account for 86.7% of India's total lansoprazole export value. The remaining 100 destination countries collectively receive the other 13.3%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Lansoprazole to India?

18 origin countries · Total import value: $8.6M

India imports lansoprazole from 18 countries with a combined import value of $8.6M. The largest supplier is ISRAEL ($8.3M, 10 shipments), followed by UNITED STATES and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Lansoprazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	ISRAEL	$8.3M	10	97.3%
2	UNITED STATES	$178.0K	44	2.1%
3	CANADA	$19.4K	37	0.2%
4	ITALY	$12.5K	13	0.1%
5	BRAZIL	$4.6K	19	0.1%
6	UNITED KINGDOM	$4.6K	1	0.1%
7	CHINA	$4.4K	11	0.1%
8	GERMANY	$3.6K	2	0.0%
9	SINGAPORE	$2.7K	1	0.0%
10	JAPAN	$1.6K	1	0.0%

Showing top 10 of 18 origin countries

ISRAEL is the largest supplier of lansoprazole to India, accounting for 97.3% of total import value. The top 5 origin countries — ISRAEL, UNITED STATES, CANADA, ITALY, BRAZIL — together supply 99.8% of India's lansoprazole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Lansoprazole — Export Intelligence Video

Visual overview of India's lansoprazole import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's lansoprazole pharmaceutical import and export market — $290.2M in total trade, 316 verified manufacturers, and 105 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Lansoprazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, lansoprazole is approved under multiple Abbreviated New Drug Applications (ANDAs), indicating a well-established generic market. Notably, Wockhardt Limited received approval for lansoprazole delayed-release capsules USP, 15 mg (OTC) on May 14, 2012. The FDA's Orange Book lists numerous approved ANDAs for lansoprazole, reflecting its widespread acceptance. The absence of current import alerts for lansoprazole suggests compliance with FDA standards. Given that 316 Indian exporters are active in this market, adherence to FDA regulations is crucial for maintaining market access.

2EU & UK Regulatory Framework

In the European Union, lansoprazole has undergone various regulatory evaluations. For instance, the European Medicines Agency (EMA) conducted a referral procedure for Agopton (lansoprazole) in September 2006 to harmonize product information across member states. (ema.europa.eu) Additionally, the EMA has assessed periodic safety update reports for lansoprazole, with the most recent evaluation in October 2022. (ema.europa.eu) In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a Class 4 Medicines Notification in February 2025 regarding a minor labeling error for lansoprazole gastro-resistant hard capsules 15 mg. (gov.uk) Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for market authorization in these regions.

3WHO Essential Medicines & Global Standards

Lansoprazole is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in global health. It meets international pharmacopoeia standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across markets.

4India Regulatory Classification

In India, lansoprazole is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensation. The National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for essential medicines; however, specific pricing details for lansoprazole should be verified with the latest NPPA notifications. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for compliance with export regulations.

5Patent & Exclusivity Status

The primary patents for lansoprazole have expired, leading to a competitive generic market. This expiration has facilitated the entry of multiple manufacturers, including Indian exporters, into global markets.

6Recent Industry Developments

In October 2022, the EMA concluded a periodic safety update report for lansoprazole, resulting in variations to the terms of marketing authorizations. (ema.europa.eu) In February 2025, the UK's MHRA issued a Class 4 Medicines Notification due to a labeling error on lansoprazole capsules, highlighting the importance of accurate product information. (gov.uk) These developments emphasize the need for continuous regulatory compliance and vigilance in the pharmaceutical industry.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Lansoprazole

Retail & reference prices across 9 markets vs. India FOB export price of $15.78/unit

Global Price Benchmark for Lansoprazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA's Orange Book, generic versions of Lansoprazole 30 mg capsules are widely available, contributing to competitive pricing.
United Kingdom	$0.28	GBP	The NHS Drug Tariff lists Lansoprazole 30 mg capsules, with prices reflecting the UK's centralized procurement system.
Germany	$0.27	EUR	The Federal Joint Committee (G-BA) in Germany includes Lansoprazole 30 mg capsules in its pharmaceutical guidelines, influencing reimbursement rates.
Australia

Supply Chain Risk Assessment — Lansoprazole

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Lansoprazole, has historically relied heavily on China for Key Starting Materials (KSMs) and certain Active Pharmaceutical Ingredients (APIs). This dependency has exposed the supply chain to vulnerabilities, particularly when Chinese manufacturers faced shutdowns due to environmental regulations and compliance issues. For instance, in 2018, several Chinese API producers were closed for failing to adhere to pollution norms, leading to supply disruptions and increased costs for Indian pharmaceutical companies.

In response to these challenges, the Indian government introduced the Production Linked Incentive (PLI) scheme to bolster domestic API manufacturing and reduce reliance on imports. This initiative aims to enhance local production capabilities, promote technological advancements, and ensure a more resilient supply chain for critical drugs like Lansoprazole. (pharmanow.live)

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a significant concentration in Lansoprazole exports from India, with the top five exporters accounting for 79.8% of the total export value. Notably, SANDOZ PRIVATE LIMITED alone contributes 54.8% of this share. Such concentration poses a single-source risk, where disruptions affecting these key suppliers could have a disproportionate impact on global supply.

Access Complete Lansoprazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,867 transactions across 105 markets.

Request Demo View Pricing

Frequently Asked Questions — Lansoprazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top lansoprazole exporters from India?

The leading lansoprazole exporters from India are SANDOZ PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, PAR FORMULATIONS PRIVATE LIMITED, and 12 others. SANDOZ PRIVATE LIMITED leads with 54.8% market share ($159.0M). The top 5 suppliers together control 79.8% of total export value.

What is the total export value of lansoprazole from India?

The total export value of lansoprazole from India is $290.2M, recorded across 4,867 shipments from 316 active exporters to 105 countries. The average shipment value is $59.6K.

Which countries import lansoprazole from India?

India exports lansoprazole to 105 countries. The top importing countries are CANADA (54.9%), UNITED STATES (20.7%), TANZANIA (5.0%), FRANCE (3.1%), GUATEMALA (2.9%), which together account for 86.7% of total export value.

What is the HS code for lansoprazole exports from India?

The primary HS code for lansoprazole exports from India is 30049034. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Lansoprazole

Lansoprazole

Top Lansoprazole Exporters from India

Top Countries Importing Lansoprazole from India

Who Supplies Lansoprazole to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Lansoprazole — Export Intelligence Video

Regulatory Landscape — Lansoprazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Lansoprazole

Supply Chain Risk Assessment — Lansoprazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Lansoprazole Trade Intelligence

Frequently Asked Questions — Lansoprazole Exports from India

Who are the top lansoprazole exporters from India?

What is the total export value of lansoprazole from India?

Which countries import lansoprazole from India?

What is the HS code for lansoprazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of lansoprazole exports from India?

Which ports handle lansoprazole exports from India?

Why is India a leading exporter of lansoprazole?

What certifications do Indian lansoprazole exporters need?

How many buyers import lansoprazole from India?

What is the market share of the top lansoprazole exporter from India?

Analysis Methodology